EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thiamine-responsive megaloblastic anemia

Medina Kh. Gurzhikhanova, M. A. Maschan

Pediatric Hematology/Oncology and Immunopathology · 30.06.2026 · 25 (2) · 183-190

DOI: 10.24287/j.1121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Hematology/Oncology and Immunopathology, online erschienen am 30.06.2026. Verfasst von Medina Kh. Gurzhikhanova und 1 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thiamine-responsive megaloblastic anemia (TRMA), also known as Rogers syndrome, is a rare autosomal recessive disorder first described by Dr. Lon E. Rogers et al. in 1969. This condition is defined by a classic triad of symptoms comprising megaloblastic anemia, diabetes mellitus and sensorineural hearing loss, although clinically it can still exhibit considerable phenotypic heterogeneity. The rarity of this disorder, with fewer than 200 affected individuals reported globally, coupled with its variable clinical manifestations, often leads to delayed or wrong diagnosis. TRMA is caused by mutations affecting the SLC19A2 gene which encodes the high-affinity thiamine transporter 1 essential for cellular thiamine uptake. While some manifestations of TRMA, particularly blood disorders and diabetes mellitus, respond well to high-dose thiamine supplementation, other symptoms such as sensorineural hearing loss remain irreversible.

Zitieren

APA

Gurzhikhanova, M. K., & Maschan, M. A. (2026). Thiamine-responsive megaloblastic anemia. Pediatric Hematology/Oncology and Immunopathology, 25(2), 183-190. https://doi.org/10.24287/j.1121

Vancouver

Gurzhikhanova MK, Maschan MA. Thiamine-responsive megaloblastic anemia. Pediatric Hematology/Oncology and Immunopathology. 2026;25(2):183-190. doi:10.24287/j.1121

BibTeX
@article{Gurzhikhanova2026,
  author = {Gurzhikhanova, Medina Kh. and Maschan, M. A.},
  title = {Thiamine-responsive megaloblastic anemia},
  journal = {Pediatric Hematology/Oncology and Immunopathology},
  year = {2026},
  volume = {25},
  number = {2},
  pages = {183--190},
  doi = {10.24287/j.1121}
}
Kostenlos starten →